Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02117700
What this trial is testing

Fatty Liver Disease in Obese Children

Who this might be right for
ObesityNonalcoholic Fatty Liver DiseaseCardiovascular Disease
Nemours Children's Clinic 14
Testing effectiveness (Phase 2)Study completedNCT04328077
What this trial is testing

LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 101
Early research (Phase 1)Study completedNCT03610945
What this trial is testing

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 48
Testing effectiveness (Phase 2)Study completedNCT01084486
What this trial is testing

Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Wolfson Medical Center
Early research (Phase 1)Study completedNCT03213145
What this trial is testing

Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Enanta Pharmaceuticals, Inc 48
Not applicableLooking for participantsNCT04634643
What this trial is testing

Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
NAFLD
Yale University 260
Large-scale testing (Phase 3)Study completedNCT02908152
What this trial is testing

Curcumin Supplement in Nonalcoholic Fatty Liver Patients

Who this might be right for
Type 2 DiabetesNonalcoholic Fatty Liver
National Nutrition and Food Technology Institute 50
Not applicableUnknownNCT03386890
What this trial is testing

Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis

Who this might be right for
Nonalcoholic Fatty Liver DiseaseLiver SteatosisLiver Fibrosis
Beijing Friendship Hospital 400
Early research (Phase 1)UnknownNCT04913090
What this trial is testing

A Phase I Clinical Trial of XZP-5610 Tablets in Healthy Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Xuanzhu Biopharmaceutical Co., Ltd. 112
Large-scale testing (Phase 3)Study completedNCT02132442
What this trial is testing

Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes

Who this might be right for
Type 2 DiabetesNonalcoholic Fatty Liver DiseaseVitamin D Deficiency
University of Massachusetts, Worcester 12
Not applicableUnknownNCT01705522
What this trial is testing

Multimodal Approach in IBD Patients

Who this might be right for
Ulcerative ColitisCrohn's DiseaseNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Clinical Hospital Colentina 50
Testing effectiveness (Phase 2)Study completedNCT03350165
What this trial is testing

Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Kowa Company, Ltd. 118
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Post-approval studies (Phase 4)Study completedNCT05459701
What this trial is testing

Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes
Rehab Werida 50
Not applicableUnknownNCT04298736
What this trial is testing

Bariatric Surgery vs. Lifestyle Modification for NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Hospital de Clinicas de Porto Alegre 50
Testing effectiveness (Phase 2)Looking for participantsNCT07288138
What this trial is testing

A Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Eccogene 160
Not applicableStudy completedNCT00868933
What this trial is testing

Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
Chinese University of Hong Kong 159
Large-scale testing (Phase 3)Study completedNCT03439254
What this trial is testing

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
Intercept Pharmaceuticals 919
Not applicableStudy completedNCT03861819
What this trial is testing

Feasibility of VIIT in Adults With NASH

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis+1 more
Duke University 24
Early research (Phase 1)Study completedNCT03681457
What this trial is testing

Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control Subjects

Who this might be right for
Non-alcoholic Fatty Liver Disease
Novartis Pharmaceuticals 42
Next Page